Johnson & Johnson's (NYSE:JNJ) Upcoming Dividend Will Be Larger Than Last Year's
May 21
Have your own idea? Try our Stock Screener
U.S. Pharma Industry Analysis
UpdatedMay 21, 2025
DataAggregated Company Financials
Companies295
- 7D1.8%
- 3M-8.9%
- 1Y-10.1%
- YTDn/a
Over the last 7 days, the Pharma industry has risen 1.8%, driven by gains from Johnson & Johnson of 3.5%. However, the industry is down 10% over the past year. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the U.S. Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 21 May 2025 | US$1.7t | US$382.6b | US$61.2b | 17.6x | 27.5x | 4.4x |
| Fri, 18 Apr 2025 | US$1.6t | US$380.5b | US$48.4b | 16.1x | 33.8x | 4.3x |
| Sun, 16 Mar 2025 | US$1.8t | US$380.5b | US$35.2b | 16.1x | 52.6x | 4.9x |
| Tue, 11 Feb 2025 | US$1.9t | US$380.7b | US$39.1b | 18.3x | 47.9x | 4.9x |
| Thu, 09 Jan 2025 | US$1.8t | US$369.3b | US$31.3b | 17.8x | 57.5x | 4.9x |
| Sat, 07 Dec 2024 | US$1.9t | US$373.8b | US$30.6b | 19.3x | 61.2x | 5x |
| Mon, 04 Nov 2024 | US$1.9t | US$373.2b | US$29.3b | 19.6x | 64.9x | 5.1x |
| Wed, 02 Oct 2024 | US$2.0t | US$364.1b | US$25.2b | 19.4x | 79.1x | 5.5x |
| Fri, 30 Aug 2024 | US$2.1t | US$363.3b | US$19.2b | 18x | 107x | 5.6x |
| Sun, 28 Jul 2024 | US$1.9t | US$357.5b | US$12.8b | 16.3x | 152.1x | 5.4x |
| Tue, 25 Jun 2024 | US$2.0t | US$358.2b | US$14.1b | 16.3x | 139x | 5.5x |
| Thu, 23 May 2024 | US$1.9t | US$358.3b | US$14.1b | 18.2x | 134.8x | 5.3x |
| Sat, 20 Apr 2024 | US$1.8t | US$357.7b | US$29.8b | 20.3x | 60.2x | 5x |
| Mon, 18 Mar 2024 | US$1.9t | US$355.4b | US$22.5b | 19.8x | 82.7x | 5.2x |
| Wed, 14 Feb 2024 | US$1.8t | US$354.9b | US$22.8b | 31x | 80.9x | 5.2x |
| Fri, 12 Jan 2024 | US$1.8t | US$375.2b | US$33.9b | 26.6x | 52.4x | 4.7x |
| Sun, 10 Dec 2023 | US$1.7t | US$375.1b | US$33.9b | 26.6x | 48.9x | 4.4x |
| Tue, 07 Nov 2023 | US$1.6t | US$376.9b | US$33.9b | 18.9x | 48.1x | 4.3x |
| Thu, 05 Oct 2023 | US$1.6t | US$381.8b | US$43.8b | 18.5x | 37.6x | 4.3x |
| Sat, 02 Sep 2023 | US$1.7t | US$381.4b | US$43.7b | 19.6x | 39.7x | 4.5x |
| Mon, 31 Jul 2023 | US$1.7t | US$393.6b | US$61.5b | 18.5x | 28x | 4.4x |
| Wed, 28 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 18.9x | 29x | 4.4x |
| Fri, 26 May 2023 | US$1.7t | US$392.9b | US$60.5b | 18.3x | 28.1x | 4.3x |
| Sun, 23 Apr 2023 | US$1.7t | US$402.6b | US$63.3b | 17.8x | 26.3x | 4.1x |
| Tue, 21 Mar 2023 | US$1.6t | US$401.1b | US$69.3b | 15.6x | 22.5x | 3.9x |
| Thu, 16 Feb 2023 | US$1.6t | US$401.8b | US$68.4b | 18.6x | 24.1x | 4.1x |
| Sat, 14 Jan 2023 | US$1.7t | US$403.7b | US$70.6b | 17.6x | 24.6x | 4.3x |
| Mon, 12 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.5x | 24.8x | 4.3x |
| Wed, 09 Nov 2022 | US$1.7t | US$403.8b | US$71.4b | 14.9x | 23.6x | 4.2x |
| Fri, 07 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 12.4x | 22x | 3.9x |
| Sun, 04 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 14.6x | 21.8x | 3.9x |
| Tue, 02 Aug 2022 | US$1.7t | US$405.2b | US$69.7b | 21.3x | 23.8x | 4.1x |
| Thu, 30 Jun 2022 | US$1.7t | US$392.6b | US$64.9b | 21.2x | 25.9x | 4.3x |
| Sat, 28 May 2022 | US$3.4t | US$414.0b | US$71.9b | 23.3x | 47.2x | 8.2x |
Price to Earnings Ratio
47.2x
Current Industry PE
- Investors are pessimistic on the American Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 27.5x which is lower than its 3-year average PE of 51.9x.
- The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 5.2% per year over the last three years,
- Revenues have also declined 2.6% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Comparison
How does U.S. Pharma compare with similar industries?
| US Market | 0.50% | |
| Healthcare | 2.31% | |
| Pharma | 1.76% | |
| Pharma | 1.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | US$153.66 | 3.5% +US$12.6b | 1.6% | PE17x | |
| PFE Pfizer | US$23.52 | 2.8% +US$3.7b | -17.6% | PE17x | |
| MRK Merck | US$77.97 | 1.7% +US$3.4b | -40.4% | PE11.2x | |
| BMY Bristol-Myers Squibb | US$47.87 | 2.7% +US$2.6b | 13.2% | PE18x | |
| RGC Regencell Bioscience Holdings | US$449.55 | 44.0% +US$1.8b | 8,118.5% | PB711.8x |
